Research and innovation news

Greater Manchester health and care partners announce new multi-million pound health innovation accelerator focused on rapidly improving the diagnosis and treatment of disease across 2,8m GM population

Greater Manchester Researchers have shown for the first time that malfunctioning behaviour of a type of immune cell is linked to specific symptoms of long-COVID.

The world’s first participant in a new COVID-19 trial taking place at MFT, is part of research that may provide important protection for people with a weakened immune system.

Researchers tell an international conference that a new gene therapy for Sanfilippo disease – also known as childhood dementia – has shown promising early results in a proof-of-concept study.

A 20-month-old baby girl has become the first child in the UK to receive a life-saving gene therapy treatment for the fatal disorder, metachromatic leukodystrophy disease (MLD). 

A world-first genetic test to establish if a newborn baby is vulnerable to deafness if treated with a commonly used antibiotic, has been conditionally recommended by NICE.

Children with cancer in Greater Manchester and Lancashire could be given new hope after a funding boost for research into experimental cancer treatments.